Annals of Intensive Care

Table 4 ROC analysis for predicting 28-day mortality in patients with HH

From: Prognostic impact of ICG-PDR in patients with hypoxic hepatitis

Parameter	AUROC	95 % CI
BL-ICG-PDR	0.81	0.68–0.93
24-ICG-PDR^a	0.88	0.76–0.99
48-ICG-PDR^b	0.96	0.90–1.00
BL-Lactate	0.74	0.60–0.88
24-Lactate	0.70	0.53–0.87
48-Lactate^b	0.71	0.54–0.88
BL-SOFA	0.69	0.54–0.83
24-SOFA	0.68	0.52–0.83
48-SOFA^b	0.73	0.58–0.89
BL-INR	0.66	0.51–0.81
24-INR^a	0.69	0.53–0.85
48-INR^b	0.76	0.61–0.91
BL-AST	0.63	0.48–0.78
24-AST	0.76	0.61–0.90
48-AST^b	0.72	0.54–0.89

AST aspartate aminotransferase level, INR international normalized ratio
^aAUROC p < 0.05 24-ICG-PDR vs. 24-INR
^bAUROC p < 0.05 48-ICG-PDR vs. 48-Lactate, 48-SOFA, 48-INR, 48-AST

Back to article page